The Future of JAKs in Dermatology
Dermatologists weigh in on the benefits and potential drawbacks of prescribing JAK inhibitors. With Ted Rosen, MD, FAAD “A number of cytokine receptors signal via JAK1, 2, 3 and TYK2, collectively known as janus kinases (JAKs) and their associated signal transducer and activators of transcription (STATs). JAK inhibition can simultaneously block the function of multiple, […]
A Recent Review of Isotretinoin
Dr. Hilary Baldwin discusses the latest with isotretinoin, including COVID risk, rhabdomyolysis risk, the iPLEDGE program, and the ongoing birth control quandary. Hilary Baldwin, MD, Medical Director of the Acne Treatment & Research Center, Brooklyn, New York, and Clinical Associate Professor, Rutgers Robert Wood Johnson Medical Center, New Brunswick, New Jersey. “This is not the […]